News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • In a new study, Dana-Farber researchers find that BRCA1 and BRCA2 testing for young women with breast cancer reaches new high levels. Results of these genetic tests are increasingly used to guide treatment and many who don’t carry such mutations still opt for bilateral mastectomy.

Tags: BreastCancer, Genetics

  • Christopher Lathan, MD, MS, MPH, is the new medical director of Dana-Farber Cancer Institute at St. Elizabeth's Medical Center. The partnership between Dana-Farber and St. Elizabeth's enables patients to receive the benefit of Dana-Farber's advances in care and research at their local hospital.

Tags: Appointments

  • Dana-Farber investigators receive $13.3 million in funding to study whether some groups of patients with DCIS who do not benefit from standard treatment, could be effectively managed with surveillance alone.

Tags: BreastCancer

  • Researchers found a way of differentiating angiocentric gliomas from other low-grade pediatric brain tumors and developed a pathological test that will help children avoid unnecessary and potentially damaging additional therapies.

Tags: BasicResearch, ChildhoodCancer, BrainTumors

  • Dana-Farber Cancer Institute today announced an immuno-oncology collaboration with potential applicability in a wide range of oncology indications with Array BioPharma.

Tags: Partnerships, Immunotherapy

  • Clinical genomic sequencing is feasible in pediatric oncology and can be used to recommend therapy or pinpoint diagnosis in children with solid tumors according to research led by Dana-Farber/Boston Children's Cancer and Blood Disorders Center. The findings, published in JAMA Oncology, represent a significant step in making precision medicine available to children with cancer.

Tags: ChildhoodCancer, TargetedTherapy, Genetics

  • Dana-Farber Cancer Institute is joining 69 of the nation's leading cancer centers in the call for increased HPV vaccination for the prevention of cancer.

Tags: CervicalCancer, Prevention, GynecologicCancers

  • Research by Dana-Farber scientists reveals genes with monoallelic expression are an important source of genetic diversity among people and also may help explain the genetic variation among cancer cells in a tumor.

Tags: BasicResearch, Genetics

  • Three Dana-Farber researchers, writing in a special issue of JAMA published today, make the case for policies and practices that give terminally ill patients more control over how and where they will die.

Tags: ColonCancer, EndOfLife, LungCancer

  • Dana-Farber researchers identify an overactive genetic regulator that could aid in developing strategies to combat drug resistance in ovarian cancer.

Tags: BasicResearch, OvarianCancer, GynecologicCancers

Showing 1-10 of 658 items